Enhanced curcumin loaded nanocellulose: a possible inhalable nanotherapeutic to treat COVID-19

Abstract

Nanocellulose/polyvinyl alcohol/curcumin (CNC/PVA/curcumin) nanoparticles with enhanced drug loading properties were developed by the dispersion of nanocellulose in curcumin/polyvinyl alcohol aqueous medium. Due to the physical and chemical nature of sulphuric acid hydrolyzed nanocellulose and the antiviral properties of curcumin, the possibility of using these nanoparticles as an inhalable nanotherapeutic for the treatment of coronavirus disease 2019 (COVID-19) is discussed. The adsorption of curcumin and PVA into nanocellulose, and the presence of anionic sulphate groups, which is important for the interaction with viral glycoproteins were confirmed by Fourier transform infrared (FTIR) spectroscopy. FESEM images showed that the diameter of nanocellulose ranged from 50 to 100 nm, which is closer to the diameter (60–140 nm) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The solubility of poorly water-soluble curcumin was increased from 40.58 ± 1.42 to 313.61 ± 1.05 mg/L with increasing the PVA concentration from 0.05 to 0.8% (w/v) in aqueous medium. This is a significant increase in the solubility compared to curcumin’s solubility in carboxymethyl cellulose medium in our previous study. The drug loading capacity increased by 22-fold with the addition of 0.8% PVA to the nanocellulose dispersed curcumin solution. The highest drug release increased from 1.25 ± 0.15 mg/L to 17.11 ± 0.22 mg/L with increasing the PVA concentration from 0 to 0.8% in the drug-loaded medium. Future studies of this material will be based on the antiviral efficacy against SARS-CoV-2 and cell cytotoxicity studies. Due to the particulate nature, morphology and size of SARS-CoV-2, nanoparticle-based strategies offer a strong approach to tackling this virus. Hence, we believe that the enhanced loading of curcumin in nanocellulose will provide a promising nano-based solution for the treatment of COVID-19.

Graphical abstract

Introduction

High abundance, the relative ease with which its characteristics can be tuned through chemical modification, ease of formation into various polymeric architectures including hydrogels, nanoparticles, microspheres, beads, coatings etc. and reported biodegradability and biocompatibility properties have led to the use of celluloses in numerous applications of biomedical field (Ummartyotin et al. 2015; Yang et al. 2019). With this plenty of favorable chemical and physical properties, we believe that cellulose-based materials can be used as promising candidates in the development of medications for COVID-19 and/or enhancement of therapeutic efficacy of COVID-19 related medications. With the latest total number of reported cases > 171 million individuals, the alarming and accelerated dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into a global pandemic has driven the need for quickly producible and reliable therapeutics (WHO 2021). Therefore, it is a great challenge for the researchers on the development of a vaccine/drug against the novel coronavirus.

Nanoparticles (NPs) have recently acquired immense importance as therapeutic delivery vehicles. These nanoformulations not only improve stability, but they also provide efficient delivery of drugs to targeted sites and long-term release. NPs can be surface-engineered with diverse kinds of treatments due to their unique physicochemical features, such as high surface-area-to-volume ratio, varying size and shape with distinct surface charge, making them a highly customized carrier for nanoformulations (Patra et al. 2018). Among different types of nanoparticles, biopolymer nanoparticles such as nanocelluloses are intriguing options for controlled therapeutic delivery applications owing to their stimuli-responsiveness, nontoxic, biocompatibility and biodegradability features. In previous studies, nanocelluloses have been used as carriers for various types of antivirals (Gunathilake et al. 2020a). For example, Zoppe et al. (2014) synthesized nanocelluloses by sulfuric acid hydrolysis to carry multivalent displays of tyrosine sulfate mimetic ligands and tested their efficiency in inhibiting alphavirus infection. Nanocrystal surfaces produced by sulfuric acid hydrolysis were decorated with anionic sulfate groups. Nanocellulose bearing multivalent displays of tyrosine sulfate mimetic groups showed increased inhibitory effect on alphaviral infection. In addition, Vedula et al. (2016) synthesized carboxymethyl cellulose acetate butyrate nanoparticles to deliver less aqueous soluble antiviral drug acyclovir (ACV). In vitro release results showed that the percentage of drug release from ACV loaded nanoparticles (nearly 55%) was ten times higher than the release from the pure drug (nearly 5%) over a period concerned. It was attributed to the increased surface area of nanoparticles enhancing the dissolution rates of ACV drug and increased release rates. In addition, it is reported that due to the negative surface charges, the sulfuric acid hydrolyzed nanocelluloses are well-dispersed in aqueous solutions and form a colloidal suspension. Recent studies report that the SARS-CoV-2 spike (S) glycoprotein is slightly more positively charged than SARS-CoV's S proteins because it comprises four highly positive charged protein moieties and five less negative charged moieties. This might help it bind negatively charged areas of other molecules more efficiently through non-specific and specific interactions (Hassanzadeh et al. 2020). In fact, that sulphuric acid hydrolyzed CNC surfaces having–OSO₃⁻groups, it will provide the ability to electrostatically interact with the positively charged spike glycoproteins of SARS-CoV-2 (Roman and Winter 2004). This binding of nanocellulose with viral glycoproteins will prevent the interaction of the virus with angiotensin-converting enzyme 2 (ACE2) of cell receptors and inhibit the viral entry into the host cells. Recent studies have used this phenomenon to neutralize SARS-CoV-2. Schoof et al. (2020) developed nanobodies that disrupt the interaction between Spike and ACE2. Electron microscopy revealed that nanobody binds spike in a fully inactive conformation with its receptor binding domains locked into their inaccessible downstate, incapable of binding ACE2. In another study, Zhang et al. (2021) developed an inhalable formulation by mixing ACE2-containing nanocatchers with mucoadhesive excipient as the competitor with host cells for virus binding to protect cells from SARS-CoV-2 infection. Their results indicated that the mucoadhesive excipient introduced significantly prolong the retention of nanocatchers in the lung. In addition, the successful inhibition of pseudovirus infection using the ACE2-containing cellular nanovesicles was demonstrated in the ACE2-expressing mouse model.

Alternative therapies such as herbal/traditional medicines have been investigated to treat viruses for a long time and have gained interesting results in many studies. Among various types of herbal medications, many researchers have introduced curcumin as a potential antiviral drug to treat viruses. For example, Ting et al. (2018) studied the inhibitory effect of curcumin carbon dots on the process of viral RNA replication by using a coronavirus model (porcine epidemic diarrhoea virus (PEDV)). Curcumin carbon dot (CCM-CDs) therapy may alter virus's surface protein, preventing it from entering the cell. Furthermore, it may prevent synthesizing negative-strand RNA, viral budding, and reactive oxygen species accumulation by PEDV. Treatment with CCM-CDs also inhibits viral replication by increasing the production of interferon-stimulating genes (ISGs) and pro-inflammatory cytokines. Besides, curcumin has gained tremendous attention in the treatment of COVID‐19 infection in recent researches. A molecular docking investigation by Khaerunnisa et al. (2020) showed that curcumin is one of the herbal medicines that may act as a potential inhibitor of COVID-19 main protease. In another study, Wen et al. (2007) showed the activity of curcumin against SARS-CoV 2 replication and inhibition of SARS-CoV main protease. The receptor-ligand complexes of the turmeric compounds and drugs used in experimental Covid-19 therapies were studied by Emirik (2020) in terms of docking scores and the binding free energy of protein–ligand complexes. Their results indicated that the turmeric spice can inhibit the SARS-CoV-2 vital proteins and can be used as a therapeutic or protective agent against SARS-CoV-2 via inhibiting key proteins of the SARS-CoV-2 virus. According to computational modeling and simulations studies by Saadat et al. (2020) the interaction and stability of the docked keto and enol forms of curcumin with SARS-CoV-2 spike glycoprotein were verified by molecular dynamics simulations, free energy binding, and interaction energy. Similarly, Suravajhala, Parashar et al. (2020) found that curcumin possesses an antiviral protein binding affinity for SARS-CoV-2 proteins. Dandapat et al. (2020) also indicated that catechin and curcumin interact with corona (SARS-CoV2) viral spike protein and angiotensin converting enzyme 2 of the human cell membrane. Furthermore, by using system biology tools, Chen et al. (2020) reported that a combination of Vitamin C, curcumin, and glycyrrhizic acid may modulate the immunological and inflammatory responses linked with coronavirus infections. Moreover, Manoharan et al. (2020) and Zahedipour et al. (2020a) recently reviewed curcumin's possible benefits in treating COVID19 infection.

Pulmonary or inhalation drug delivery provides a more convenient and efficient alternative for intravenous or oral administration of medications in order to reduce side effects. Recent studies suggest using silver nanoparticles to treat COVID-19 in its early stages by inhalation therapy. Zachar (2020) proposed a model technique and computation to achieve the antiviral minimal inhibitory concentration of silver particles in different regions of the respiratory tract as first-line therapy for halting infection development. The standard 5 μm diameter droplet inhalation is suggested mainly for colloidal silver particles of 5 nm size. Similarly, Sarkar (2020) proposed nebulization of water dispersed 10 nm size silver nanoparticles with bronchodilators using a simple nebulizer machine or bi-level ventilation to yield better results for COVID-19 patients. AgNP's antiviral actions may be due to its binding to the surface glycoproteins of RNA viruses, which prevents the virus from fusing with host cells. Though several studies have suggested the inhalation delivery of silver nanoparticles as a potent treatment for COVID-19, these metal nanoparticles' adverse acute and chronic health effects are not well understood. Compared to metal nanoparticles, bionanoparticles are considered safe in biomedical applications due to their inherent biodegradability and biocompatibility properties. Nanocellulose manufacture has been found to be safe (Environment Canada has listed nanocelluloses as a “nontoxic” domestic material), inhaled spray-dried nanocellulose powders have demonstrated no deleterious effects on the lungs, and ecotoxicological characterization has demonstrated nanocelluloses to have minimal toxicity potential and environmental risk (Kovacs et al. 2010). Furthermore, the studies of the interaction of nanocellulose with a multi-cellular in vitro model of the epithelial airway barrier following realistic aerosol exposure by Endes et al. (2015) showed that shorter nanocelluloses (237 ± 118 × 29 ± 13 nm) are readily engulfed and cleared from the cell surface. In another study, Vartak et al. (2021) formulated an aerosolized nanoliposomal carrier for remdesivir against SARS-CoV-2. In this study, the authors developed specialized, nanosized particles containing the drug remdesivir that can be administered directly into the lungs. This could drastically minimize side effects, enhance efficacy and allow easy self-administration at the site of infection. Results demonstrated minimal cytotoxicity in A549 cells and retained monolayer integrity of Calu-3 cells. Remdesivir showed sustained release, with complete drug release obtained within 50 h in simulated lung fluid.

Systemic drug delivery by inhalation (oral and nasal) is a promising alternative to oral or parenteral administration of drugs. High bioavailability, rapid onset of action due to wide surface area for absorption, self-administration, increased patient compliance, non-invasive nature, minimal drug degradation, and high solute permeability are all benefits of inhaled drug delivery. Antibiotics, proteins, peptides, chemotherapeutics, interferon, antitrypsin, protease inhibitors, deoxyribonucleases, vaccines, and many other drugs have been delivered locally via the pulmonary route (Mahmud and Discher 2011; Sung et al. 2007). Liposomes, solid lipid nanoparticles, lipid or polymeric micelles, polymeric nanoparticles, and dendrimers are some of the nanocarriers that have been studied as potential drug delivery systems. In this study, we suggest the use of nanocellulose for inhalable delivery of the antiviral drug curcumin. Though several studies have employed biopolymer nanoparticles such as gelatin, chitosan, alginate, and synthetic polymers, including poloxamer, poly(lactic-co-glycolic) acid, and poly(ethylene glycol) as nanocarriers, a limited number of studies have reported on the use of nanocellulose as a carrier for nasal drug delivery (Menon et al. 2014; Muralidharan et al. 2015; Thennakoon et al. 2021). The use of sulphuric acid hydrolysis to prepare nanocellulose will provide many advantages such as ease of the preparation of tunable particle size, morphology and surface characteristics, including the incorporation of anionic surface charge. Integration of those features to nanocellulose will help to improve drug loading capacity, and stronger barriers cross permeability, enhanced cellular uptake, longer lung retention, and a better possibility of penetrating mucus in the airway. Due to these facts, we believe this study will provide a better initiative to consider nanocellulose as a novel nanocarrier for future inhalable drug delivery systems.

Since curcumin is poorly water-soluble, in this study, we use water-soluble biodegradable biopolymer, PVA, to improve the solubility of curcumin. Though Tween 20 and carboxymethyl cellulose have succeeded in improving the curcumin solubility from our previous studies, this study requires a surfactant that improves the curcumin solubility in the acidic medium and hence in this study, pH-independent water-soluble PVA has been used. Due to hydroxyl and acetyl groups, we believe that PVA will form micelles-like structures in the aqueous medium and facilitate enhancing the solubility of curcumin. The enhancement of curcumin's solubility will significantly affect the improvement of the drug loading in nanocellulose. Enhanced loading of curcumin in nanocellulose will provide a promising nano-based approach for the treatment of COVID-19.

Materials and methods

Materials

Microcrystalline cellulose with a particle size of 20 µm (CAS:9004-34-6) was purchased from Sigma-Aldrich. Hydrochloric acid, methanol and sulfuric acid were purchased from Friendemann Schmidt Chemicals. Polyvinyl alcohol (Kuraray Poval 220S, molecular weight 78 kDa, viscosity 27–33 mPa∙s, degree of hydrolysis of 87%–89%) was purchased from Kuraray Co., Ltd., Kurashiki, Japan.

Methodology

Extraction of curcumin

Curcumin was extracted from dried rhizomes of turmeric using a solvent extraction method. 500 g of dried rhizomes were crushed and immersed in methanol for 3 days. Then, the extract was filtered using the Whatman filter paper (pore size 0.2 µm). After that, the filtrate was evaporated under a vacuum to produce a semi-solid oily mass.

Preparation of CNCs

The sulfuric acid hydrolysis technique was used to synthesize cellulose nanocrystals (CNCs). 10 g microcrystalline cellulose (MCC) was first mixed with distilled water in a flask. The flask was placed in an ice bath, and sulfuric acid was added dropwise (to avoid a temperature spike) while constantly stirring until the required acid concentration of 64% (w/w) was obtained. After that, the suspension was rapidly stirred for 60 min at 45 °C. Following acid hydrolysis, the suspension was nixed with cooled deionized water 1:10 (v/v) to stop the reaction and washed with deionized water using centrifuge cycles (at 6000 rpm for 10 min). The clear solution was removed from the precipitate, and distilled water was added to the recipient and mixed to remove excess acid from the suspension. This process was carried out five times. The slurry was then placed on dialysis membranes, dialyzed for 24 h, and then dipped in distilled water for another 24 h until it reached a neutral pH. Finally, the CNC suspension was subjected to a 10 min ultrasound treatment to prevent the formation of aggregates (Sampath et al. 2017; Shi et al. 2021; Udeni Gunathilake et al 2016).

Solubility studies

The solubility of curcumin was determined in a slightly acidic medium (pH 6). This is to maintain the experimental condition similar to the pH of mucosal airway and to ensure the stability of curcumin. The pH of the medium was adjusted to pH 6 by adding hydrochloric acid dropwise to distilled water. After that, an excess amount of curcumin (100 mg) was added to the prepared acidic (pH 6) aqueous medium (100 mL) and mixed with PVA. To study the effect of PVA concentration on the solubility of curcumin, a series of curcumin solutions were prepared using different concentration of PVA [0.05%, 0.1%, 0.2%, 0.4% and 0.8% (w/v)]. Then sample containers were wrapped in aluminum foil to prevent photo-degradation. After that, the mixture was stirred using a magnetic stirrer (at a speed of 350 rpm) for 12 h. Finally, the solutions were centrifuged (10,000 rpm for 10 min) and dissolved curcumin was determined using UV–Vis spectroscopic method. The tests were performed in triplicates, and average values were reported.

Drug loading

Excess amount of curcumin (100 mg) was added to acidic (pH 6) aqueous medium (100 mL) with PVA at different concentration [0.05%, 0.1%, 0.2%, 0.4% and 0.8% (w/v)] and stirred for 12 h. After that, the solutions were centrifuged (10,000 rpm for 10 min) and supernatant was separated. A constant amount of CNC (0.42 g) was then dispersed in 100 mL supernatants and stirred (at a speed of 350 rpm) for 24 h. After that, the CNC suspensions (in PVA medium) were centrifuged (6000 rpm for 20 min), and the remaining amount of curcumin in the supernatant was determined using UV–Vis spectroscopic method. The drug loading capacity of CNC was calculated using Eq. (1). The tests were performed triplicates and average values were reported.

$$\mathrm{Drug}\mathrm{loading}\mathrm{capacity}=\frac{\mathrm{Absorbed}\mathrm{amount}\mathrm{of}\mathrm{drug}\mathrm{from}\mathrm{the}\mathrm{solution}}{\mathrm{Weight}\mathrm{of}\mathrm{nanocellulose}}\times 100\%$$ 1

In vitro drug release

Excess amount of curcumin (100 mg) was added to acidic (pH 6) aqueous medium (100 mL) with PVA at different concentration [0.05%, 0.1%, 0.2%, 0.4% and 0.8% (w/v)] and stirred for 12 h. After that, the solutions were centrifuged (10,000 rpm for 10 min) and supernatant was separated. A constant amount of CNC (0.42 g) was then dispersed in 100 mL supernatants and stirred (at a speed of 350 rpm) for 24 h. After that, the CNC suspensions (in PVA medium) were centrifuged (6000 rpm for 20 min), and curcumin loaded CNC was air dried. The composition of nanocellulose used for in vitro drug release studies is mentioned in Table 1.

Table 1.

The composition of nanocellulose used for in vitro drug release studies

Nanoformulations	The composition of the drug loading medium			The amount of loaded curcumin (per 1 g of CNC)
	CNC (w/v) %	Curcumin (w/v) %	PVA (w/v) %
CNC/PVA0/curcumin	0.42	0.1	0	0.40 ± 0.01
CNC/PVA0.05/curcumin	0.42	0.1	0.05	1.46 ± 0.20
CNC/PVA0.1/curcumin	0.42	0.1	0.1	3.87 ± 0.15
CNC/PVA0.2/curcumin	0.42	0.1	0.2	7.68 ± 0.20
CNC/PVA0.4/curcumin	0.42	0.1	0.4	8.36 ± 0.78
CNC/PVA0.8/curcumin	0.42	0.1	0.8	8.90 ± 0.20

In vitro drug release from curcumin loaded CNCs were studied in an acidic medium (pH 6). Drug loaded CNC was dispersed in an acidic medium, and the concentration of released curcumin was determined using the UV–Vis spectroscopic method. The drug release was determined by withdrawing 3 mL of the medium at prefixed time intervals and returned it back to the solution after the analysis. The tests were replicated three times, and average values were obtained.

Drug activity

The UV–visible spectra of pure curcumin and the curcumin released from nanocellulose were obtained by scanning the drug solutions using UV–visible spectrophotometer (scan range 300–700 nm). Drug activity was determined by comparing the spectra [the absorption maxima (λ max)] of pure and released drugs.

FTIR study

The FTIR spectra of extracted curcumin, PVA, nanocellulose, curcumin loaded nanocellulose, and curcumin/PVA loaded nanocellulose were obtained using the KBr pellet method and PerkinElmer FTIR spectrometer over the range 4000–500 cm⁻¹.

Morphology

The morphology of the microcrystalline cellulose and nanocellulose were studied using a field emission scanning electron microscope (FESEM, Auriga, Zeiss). Few drops of samples dispersed in distilled water were put on the surface of aluminum foil and air-dried before the analysis. The FESEM observation was done at 1 kV accelerating voltage.

Results and discussion

FTIR study

Figure 1 illustrates the FTIR spectra of extracted curcumin, CNC and curcumin incorporated CNC. The classic approach of running the IR spectrum is by preparing a KBr disc. Attenuated total reflection (ATR) is a technique that enables direct sample measurement for FTIR. Some research indicated that both these methods give the same result. However, we found from this study that the KBr disc technique has a higher resolution than the ATR. The FTIR spectrum of CNC demonstrated pure cellulose's characteristic peaks. The broad peak around 3434 cm⁻¹ is due to the O–H stretching vibration of the hydrogen-bonded cellulosic hydroxyl groups. Here the hydrogen-bonded O–H stretch peak is much broader because the hydrogen bonds vary in strength (Larsen et al. 2007). The peak that appeared at 1207 cm⁻¹ is due to the C-H stretching vibration of cellulose (Sajjad et al. 2020). The peaks that appeared at 2136 cm⁻¹ and 1647 cm⁻¹ are due to moisture absorption. 1647 cm⁻¹ peak is attributed to the H–O–H angle vibration, and the peak at 2136 cm⁻¹ is due to scission and rocking vibrations of water (Olsson and Salmén 2004). The peaks in the range of 1431–1453 cm⁻¹ is due to the symmetric bending of CH₂ and the absorption peaks at 1376–1321 cm⁻¹ related to the C–H and C–O bending vibration of the polysaccharides (Aguayo et al. 2018). The band that appeared around 1161 cm⁻¹ range was due to asymmetric stretching vibrations of C–O–C in the 1,4-glycosidic linkages of d-glucose units (Zheng et al. 2019). In addition, the removal of amorphous components during acid hydrolysis can result in substituting hydroxyl groups (–OH) by sulphate groups (O–SO₃⁻) on the nanocellulose surface. The presence of surface sulphate groups can be confirmed by the 1165 cm⁻¹ and 1431 cm⁻¹ peaks, which corresponding to the symmetric S=O (in the range of 1200–1150 cm⁻¹) and asymmetric S=O (in the range of 1430–1330 cm⁻¹) stretching vibrations, respectively. However, the sulphate stretching vibration peaks may overlap with glycosidic link vibrations. Furthermore, the weaker peak at 814 cm⁻¹ may also be due to the C–O–S stretching vibration of the sulphate group on the surface of nanocellulose (Septevani et al. 2017). As an antiviral nanotherapeutic, the interaction of nanoparticle with viral particles is an important factor, considering the antiviral drug's therapeutic efficacy. In this case, negatively charged ionized surface sulphate groups attached to nanocellulose will provide the ability to binding with the positively charged lipid bilayer of viruses.

Fig. 1.

FTIR spectra of nanocellulose, curcumin and curcumin loaded nanocellulose

The extracted curcumin FTIR spectrum is similar to the FTIR spectrum of curcumin obtained from turmeric powder in earlier research (Bich et al. 2009; Fugita et al. 2012). Furthermore, we compared and confirmed the occurrence of characteristic peaks of extracted curcumin from turmeric and commercial curcumin obtained from Himedia Co. in our prior work (Gunathilake et al. 2018). In the curcumin spectrum, the broad peak at 3464 cm⁻¹ is attributed to the stretching vibration of phenolic O–H. This OH stretch peak is less broad compared to nanocellulose’s OH stretch peak. This may be attributed to the fewer hydrogen bonding interactions in curcumin compared to nanocellulose. The peak at 2939 cm⁻¹ is responsible for the aromatic C–H stretch vibrations. The peaks at 1628 cm⁻¹ and 1603 cm⁻¹ are due to C=O stretching and aromatic ring stretching, respectively. The peak corresponding to olefinic bending vibration of C–H bound to benzene ring appeared at 1513 cm⁻¹, while C–C vibrations occurred at 1431 cm⁻¹. The peaks that appeared at 1280 cm⁻¹ and 1163 cm⁻¹ are due to the C=O stretching vibrations attached to the aromatic ring and C–O–C stretching vibrations, respectively (Ching et al. 2019). Curcumin contains three reactive functional groups linked with its various biological functions, as determined by its FTIR spectrum: one diketone moiety and two phenolic groups. Important chemical reactions related to its biological activity include C=O groups as hydrogen acceptors and C-4 as a hydrogen donor. These functional groups will also contribute to the antiviral properties of curcumin. Curcumin has been shown to inhibit SARS-CoV-2 replication by interacting with the spike glycoprotein and inhibiting ACE2, the viral non-structural protein Nsp15, or the main viral protease, according to recent research (Zahedipour et al. 2020b).

In CNC/curcumin spectrum, the characteristic peaks related to CNC functional groups are more prominent. The main feature observed in the CNC/curcumin spectrum is the increase of moisture absorption. It is evident by the broadening and shifting of the OH stretch band to a lower wavelength region and the increase of the intensity of the water peak 1644 cm⁻¹. This may be due to the introduction of hydrophobic curcumin molecules within hydrophilic cellulose chains causing exposure of more hydroxyl groups of CNC chains, which result in absorption of more water molecules. These hydrogen-bonded (with H₂O) OH groups vary in strength and require less energy for stretching vibrations. Therefore, the OH stretching band is broader and shifting to a lower wavelength region. In addition, the shifting of water peak from 1647 to 1644 cm⁻¹ was observed. This may be due to the interaction of curcumin with CNC chains. Similar findings were also reported by previous researches. In addition, the peak broadenings in the regions of 987 cm⁻¹–1165 cm⁻¹ and 813 cm⁻¹–461 cm⁻¹ were also observed due to the curcumin and CNC interactions. However, there were no new peaks appeared in the CNC/curcumin spectrum.

Figure 2 displays the FTIR spectra of PVA, curcumin loaded nanocellulose, and curcumin/PVA adsorbed nanocellulose. The FTIR spectrum of PVA indicated a broad absorption peak at 3444 cm⁻¹, corresponding to OH stretching vibration. The peaks at 2947 cm⁻¹ and 2912 cm⁻¹ are due to the C–H symmetric and asymmetric stretching vibrations. The peak at 1735 cm⁻¹ is due to the C=O and C–O stretching of the remaining acetate groups of PVA. The water peak is appeared at around 1649 cm⁻¹. The band at 1440 cm⁻¹ is due to the bending of CH₂ groups. The peaks at 1379 cm⁻¹ and 1337 cm⁻¹ are due to the bending vibrations of CH₃ groups. The peaks at 1264 cm⁻¹, 1099 cm⁻¹, 849 cm⁻¹ and 607 cm⁻¹ are due to the C–O stretching of alcohol groups. In the CNC/PVA/curcumin spectrum, a shoulder-type peak appeared just to the left of the water peak. This is corresponding to the stretching of C=O and C–O from the remaining acetate groups of PVA. There was no significant difference between CNC/curcumin spectrum and CNC/PVA/curcumin spectrum. However, the decrease in the water peak intensity and the less broadening of the OH stretch peak show CNC/PVA/curcumin absorbs less moisture than CNC/curcumin. This may be due to the hydrogen bonding interactions of PVA with CNC hydroxyls lowers the binding of water molecules to CNC chains via hydrogen bonding. Moreover, no new peaks appeared in the CNC/PVA/curcumin spectrum, indicating no chemical reactions between PVA, curcumin and CNC.

Fig. 2.

FTIR spectra of PVA, curcumin loaded nanocellulose and curcumin/PVA adsorbed nanocellulose

Morphology

The isolation of nanocellulose from microcrystalline cellulose was successfully executed using the sulphuric acid hydrolysis method. The nanocellulose 1% suspension was prepared in distilled water, and undispersed CNC aggregates were removed using a mild sonication method. After that, the suspension was dispersed in aluminum foil and air-dried. The morphology of nanocellulose was studied using FESEM under accelerating voltage of 1 kV to confirm the successful extraction of CNC. Here, the diameter and size of cellulose structures were reduced from micron to nanometer size due to the removal of amorphous microcrystalline cellulose regions, leaving nanoscale rod-like structures (Fig. 3). The diameter of the CNC ranged from 50 to 100 nm (Image J software). CNCs presented more densely packed fibrous cellulose networks due to the intermolecular hydrogen bonding and strong hydrophilic interaction between the cellulosic chains. The diameter of CNCs was similar to the values reported for CNCs obtained from sulfuric acid hydrolysis by Wulandari et al. (2016) and Nascimento et al. (2016). Wulandari et al. (2016) used 50% sulfuric acid at 40 °C, and Nascimento et al. (2016) used 63.7% sulfuric acid at 45 ºC.

Fig. 3.

FESEM images of a microcrystalline cellulose; b and c sulphuric acid hydrolyzed nanocellulose

SARS-CoV-2, a positive-sense single-stranded RNA virus, is covered by an envelope with glycoprotein spikes. SARS-CoV-2 spike glycoprotein binds to the angiotensin‐converting enzyme 2 (ACE2) receptors on the surface of host cells. The most popular treatment approaches focus on disrupting this critical event since binding the S protein to ACE2 is essential for the first infection stage.

SARS-CoV-2 particles are 60 to 140 nm in diameter (Bar-On et al. 2020). Due to the particulate nature, morphology and size of SARS-CoV-2, nanoparticle (NP)-based strategies offer a strong approach to tackling this virus. The presence of surface –OSO₃⁻ groups with negative charges and nanoscale rod-like structures of nanocellulose provide the ability to binding with the positively charged domains of spike glycoproteins of the virus. It will prevent the virus from binding with ACE2 receptors and internalizing the virus into the host cell, interfering with viral replication. The proposed inhibition mode of CNC/PVA/curcumin against SARS-CoV-2 infection is illustrated in Fig. 4. Similarly, these types of electro statistic interactions of nanomaterials have been used to combat coronavirus infections in previous studies. For example, Chen et al. (2016) studied the antiviral efficacy of graphene oxide (GO) sheets and GO sheets with silver particles (GO-Ag) against feline coronavirus (FCoV). Results indicated that negatively charged GO sheets could interact with positive charge viral lipid membrane and cause disruption of the lipid membrane.

Fig. 4.

The proposed inhibition mode of CNC/PVA/curcumin against SARS-CoV-2 infection

Solubility studies

Curcumin, a natural polyphenolic nutraceutical found in turmeric, has been linked to antioxidant, anticancer, anti-inflammatory, antiviral, and antibacterial properties; according to over 6000 citations, more than 100 clinical studies. Curcumin has been shown to have antiviral action against viruses such as the parainfluenza virus type 3, feline infectious peritonitis virus, vesicular stomatitis virus, herpes simplex virus, flock house virus, and respiratory syncytial virus. Also, recent studies indicated that different formulations of curcumin could be used to treat COVID-19 successfully (Chen et al. 2020; Jena et al. 2021; Khaerunnisa et al. 2020; Manoharan et al. 2020; Saadat et al. 2020; Suravajhala et al. 2020; Zahedipour et al. 2020). Although curcumin exhibits diverse biological activities, its bioavailability has been restricted by its poor water solubility and fast presystemic metabolism. However, many attempts have been made to overcome their bioavailability limitations, including the development of curcumin-associated nanoparticles, liposomes, micellar formulations, cyclodextrin inclusion complexes, microemulsions, and surfactants (Petchsomrit et al. 2017; Ratanajiajaroen and Ohshima 2012; Sinjari et al. 2019; Udeni Gunathilake et al. 2017a, b; Zhang et al. 2016). With reference to our previous studies, we have used synthetic surfactant (Tween 20) and pH-dependent water-soluble polymer (carboxymethyl cellulose) to enhance the solubility of curcumin (Ching et al. 2019; Gunathilake et al. 2020b). However, in this study, we are not using Tween 20 or carboxymethyl cellulose. The current research requires a more biocompatible biopolymer and possesses pH-independent solubility properties to be used in the inhalable drug delivery system. Since the upper respiratory system is slightly acidic, if we use carboxymethyl cellulose, we will not be able to obtain enhanced solubility of curcumin because carboxymethyl cellulose is less ionizable in acidic conditions. Therefore, in this research, we are using PVA, a pH-independent aqueous soluble and biocompatible biopolymer, to improve curcumin solubility. We noticed that curcumin solubility increased from 2.85 ± 0.06 to 313.61 ± 1.05 mg/L with increasing the PVA concentration from 0.05 to 0.8 (w/v%) (Fig. 5). This is a considerable improvement in solubility compared to curcumin solubility in carboxymethyl cellulose medium in our previous study, which increased from 24 ± 0.38 mg/L to 147 ± 5.66 mg/L by increasing the carboxymethyl cellulose concentration from 0.1 to 2% (w/v) in PBS medium. In addition, the viscosity of the medium increased with increasing the carboxymethyl cellulose concentration in the previous study, which limited its addition to a certain extent to the medium. However, the addition of PVA did not considerably affect the viscosity of the medium; therefore the nanocelluloses were well dispersed in the PVA medium compared to the carboxymethyl cellulose medium (Gunathilake et al. 2020b). The physical appearance of the solubility of curcumin in the acidic medium with different concentrations of PVA is displayed in Fig. 6.

Fig. 5.

Solubility of curcumin in acidic medium with different concentration of PVA

Fig. 6.

Physical appearance of the solubility of curcumin in acidic medium with different concentrations of PVA

PVA is a water-soluble, biodegradable synthetic biopolymer. PVAs are categorized into different grades based on the degree of hydrolysis (the ratio of hydroxyl to acetyl groups) and the degree of polymerization, both of which affect water solubility (Kaiwen et al. 2016; Rahman et al. 2020). The physicochemical characteristics of PVA, such as hydration, dielectric constant, conformation, and dynamics, are affected by interactions between water molecules and the –OH group of PVA in their aqueous solution. Since PVA contains both hydrophilic and hydrophobic groups, it will form a micelle-like structure and provide ideal conditions for the solubilization of weakly aqueous soluble curcumin. The formation of multiple stranded micelle-like structures contributes to changes in physical properties (Rahman et al. 2020). The rheological properties and adsorption characteristics at solid–liquid interfaces of these solutions vary from the aqueous medium. The polymer solubilized medium has a distinct microenvironment than the aqueous medium under which solubilization capabilities for sparingly soluble molecules with modified liquid–liquid interfacial tensions. Previous studies reported that the low molecular weight PVA showed a higher reduction of surface tension and faster dissolution in water. In addition, the lower degree of hydrolysis PVA polymer solubilized poor soluble drugs to a greater extent in water (Umemoto et al. 2020). In this study, we used low molecular weight PVA (78 kDa) with 87–89% degree of hydrolysis. Umemoto et al. (2020) reported that the highest solubility of the poorly water-soluble drug (amenamevir) was obtained by the dissolution with a 66% degree of hydrolyzed PVA. The lowest solubility of amenamevir was shown by the dissolution with a 99% degree of hydrolyzed PVA. Meanwhile, PVAs with a hydrolysis degree not lower than 66% could be dissolved in water (Umemoto et al. 2020).

Drug loading capacity

As curcumin is poorly water-soluble, we used water-soluble synthetic polymer PVA as a surfactant to improve curcumin’s solubility in the aqueous medium. First, the curcumin was dissolved in the PVA medium, and then nanocellulose was dispersed for the entrapment of curcumin. After the entrapment of curcumin and air-dried, the nanocellulose entrapped in PVA/curcumin medium appeared in dark yellow, while the nanocellulose entrapped in aqueous curcumin medium (without PVA) seemed in light yellow (Fig. 7).

Fig. 7.

Physical appearance of curcumin loaded CNC and PVA/curcumin loaded CNC

According to the UV–Vis analysis results, CNCs dispersed in curcumin, and PVA 0.8% solution showed the highest drug loading capacity, which was 8.90 ± 0.2 mg/g (Fig. 8). The lowest drug loading capacity was shown by nanocellulose dispersed in the aqueous curcumin medium (without PVA), which was 0.40 ± 0.01 mg/g. The drug loading capacity increased by 22-fold with the addition of 0.8% PVA to the aqueous curcumin medium. This study’s drug loading capacity was slightly higher compared to the results of our previous study, in which we used Tween 20 as a surfactant for the dissolution of curcumin. The highest curcumin loading capacity was 7.73 mg/g in the previous study. This increase may be due to the less viscosity of PVA solution, providing better dispersion of nanocellulose than Tween 20 medium.

Fig. 8.

Drug loading capacity of nanocellulose for curcumin dissolved with different concentrations of PVA

As PVA possessing the unique property of having both hydrophilic (hydroxyl) and hydrophobic (acetyl) groups, we predict that this polymer may develop a micelle-like structure and function as a polymeric surfactant. Many papers describe the development of polymer micelles as long-term circulating drug carriers. The polymeric micelles are incredibly fascinating because they trap hydrophobic drugs within their inner core and provide compact and flexible architectures. Polymeric micelles are formed at the critical micelle concentration in the aqueous medium due to the minimum energy state attainment. Umemoto et al. (2020) prepared PVA solutions with different PVA concentrations using PVAs of different hydrolysis degrees. The formation of the hydrophobic domain of the micelles was confirmed by the fluorescence intensity of pyrene emissions. Their results showed that the fluorescence emission intensity increased with increasing the PVA concentration. In addition, PVA with a lower degree of hydrolysis had lower critical micelle concentration. The 88% degree of hydrolyzed PVA showed critical micelle concentration at around 0.5% (w/v). Besides, the polymers like hydroxypropylmethylcellulose did not show an increase of fluorescence intensity with increasing its concentration. Our study used a 0.05–0.8% (w/v) PVA concentration range and 87–89% degree of hydrolyzed PVA for the dissolution of curcumin. This range is within the critical micelle concentration range of the 88% degree of hydrolyzed PVA mentioned in the previous study.

The adsorption of polymeric micelles is a feasible method to enhance the compatibility of the hydrophilic nanocellulose with the hydrophobic drug curcumin. The PVA micelles' hydrophilic domain may have an affinity for adsorption to cellulose due to its hydroxyl groups. However, not all CNC hydroxyls are accessible. Some of them are oriented towards the integral parts of nanocellulose. According to previous studies, only one half of the hydroxyls present in CNC are reactive (Akhlaghi et al. 2019). Higher drug loading capacity is necessary to ensure that the required drug dose at the target site is available to decrease drug resistance development. Furthermore, the targeted delivery of nanotherapeutics directly to the target site also increases the efficacy of the drug. As CNC/PVA/curcumin particles full fill both these conditions, we believe that this nanotherapeutic's inhalation delivery will provide a successful approach for treating the initial stages of COVID -19. Furthermore, the surfactant molecule's hydrophilic end may adsorb on the surface of cellulose nanoparticles, while the hydrophobic end may extend out, producing a non-polar surface and reducing the nanoparticle's surface tension. The presence of PVA micelles' hydrophobic ends on the surface of nanocellulose will decrease the interaction of water molecules with nanocellulose. Therefore, the hydrolytic degradation of nanocellulose will decrease, and the stability of nanocellulose in an aqueous medium will increase. In previous studies, the presence of these hydrophobic groups has rendered the polymers with lower water uptake properties and decreased hydrolytic degradation (Elmowafy et al. 2019).

In vitro drug release

The drug release was carried out in an acidic medium which is similar to the mucosal airway pH. Compared with blood and interstitial pH of 7.4, mucosal airway pH is considered acidic (Fischer and Widdicombe 2006). In the meantime, curcumin is stable in an acidic medium (85–95%) but unstable in neutral or alkaline solutions (53–62%) (Kharat et al. 2017). The stability of curcumin in acidic environments is possibly due to its conjugated diene, which is gradually destroyed when the H⁺ is removed at alkaline pH during dissociation of phenolic groups, leading to more prone positioning to degradation (Lee et al. 2013). Therefore, it is good to use curcumin as an antiviral agent in the acidic medium. Furthermore, it was reported that the curcumin was more stable in the emulsions under acidic pH conditions. Moreover, the curcumin was less prone to crystallize in the emulsions than in the aqueous solutions because curcumin has a much higher solubility in oil than in water. Similarly, the high solubility of curcumin in acidic surfactant (PVA) of this study will decrease the crystallization and increase curcumin's stability. In addition, previous studies investigated the storage stability of curcumin at 37 °C (body temperature) for 31 days. Also, no major visual distinction could be made between fresh and stored curcumin emulsions, demonstrating that the curcumin in the emulsions was reasonably stable under the storage conditions used (Kharat et al. 2017).

All the formulations displayed initial burst release within the first 30 min owing to the fraction of the drug attached weekly to the large surface area of CNCs. After that, all the formulations showed sustained drug release profiles. As shown in Fig. 9, among all the formulations, CNC/PVA0.8/curcumin showed the highest drug release of 17.11 ± 0.22 mg/L and CNC/PVA0/curcumin showed the lowest drug release of 1.25 ± 0.15 mg/L at around 390 min. It can be seen that the drug release increased with increasing the PVA concentration in the drug-loaded medium. This may be due to the improvement of drug loading and the increase of adsorption of PVA to nanocellulose with increasing the PVA concentration in the medium. The presence of a shoulder-type peak proved the attachment of PVA into nanocellulose at around 1730 cm⁻¹ of CNC/PVA/curcumin FTIR spectrum. This PVA facilitates improving the curcumin solubility in the aqueous medium by forming polymer micelles and adsorbing the hydrophobic curcumin into the core of the micelle structure. PVA is a non-ionic pH-independent water-soluble polymer, which is supposed to have the same solubilization performance regardless of the pH of the medium. Thereby, it will improve the solubility of the curcumin even in the acidic medium due to the interactions of the micelle's hydrophilic domain with water molecules.

Fig. 9.

In vitro drug release from different formulations of CNC/PVA/curcumin

Most of the reported work relevant to burst release in the pharmaceutical field focused on avoiding it from controlled release formulations. Initial burst release is disadvantageous because the initial high release rates can lead to drug doses near or above the in vivo toxic level and may be metabolized and excreted without achieving its therapeutic effect. However, in several cases, such as in targeted delivery systems, where the delivery location is highly specific, burst release may be desired at that site. In this research, the inhalable curcumin loaded nanoparticles will be delivered to the respiratory mucosal airway to treat the initial stages of SARS-CoV-2. Therefore, the initial high release rates may be advantageous as nanoparticles directly contacting the viral invaded tissues. Also, curcumin is non-toxic even at a relatively high concentration. It showed no lethal effect on healthy organs at doses as high as 8 g/day (Almosa et al. 2020).

The poor solubility of curcumin causes low in vivo bioavailability. For example, ingestion of 12 g of curcumin resulted in 29.7 ng/mL (~ 81 nM) of curcumin in human blood serum after one-hour ingestion that is far below any of the therapeutic levels identified in several in vitro studies. Previous studies concerning the antiviral activity of curcumin against RNA viruses reporting that curcumin is needed at an IC₅₀ of 40 µM to inhibit the HIV-1 integrase (Mazumder et al. 1995), effective dose against influenza A virus (IAV) is ~ 10 µM (Chen et al. 2010), for Zika Virus IC₅₀ is ~ 5–14 µM (Gao et al. 2019), for dengue virus IC₅₀ is ~ 36–66 µM (Balasubramanian et al. 2019) for chikungunya virus IC₅₀ is 10.79 µM (von Rhein et al. 2016), for vesicular stomatitis virus IC₅₀ is 4.5 µM (Mounce et al. 2017; von Rhein et al. 2016) for influenza A virus IC₅₀ is ~ 0.2 µM (Richart et al. 2018) for transmissible gastroenteritis virus IC₅₀ is 8.6 µM (Li et al. 2020) and for SARS-CoV-1 replication inhibition EC₅₀ is > 10 µM. According to the above-mentioned curcumin levels, which required reducing the RNA viruses’ response, we noticed that the in vitro release concentrations of curcumin in this study is within the required therapeutic levels.

Besides the potential of curcumin to target critical steps of the viral replication cycle, previous studies have shown that curcumin can be effectively used to treat devastating outcomes of COVID-19 infection (Zahedipour et al. 2020). For example, it can be used to treat COVID-19 associated pulmonary inflammation (Avasarala et al. 2013; Ferreira et al. 2015), pulmonary edema (Mathew et al. 2015; Sagi et al. 2014; Titto et al. 2020) and pulmonary fibrosis (Chen et al. 2008; Cutroneo et al. 2007; Punithavathi et al. 2000, 2003; Tourkina et al. 2004; Venkatesan et al. 1995; Venkatesan 1999; Xu et al. 2007), cardiovascular damage (Li et al. 2017; Sahebkar and Henrotin 2016; Salabei and Conklin 2013), kidney damage (Sun et al. 2017; Xu et al. 2018), oxidative stress in viral infection (Dai et al. 2018).

Drug activity

The chemical reactions that correspond to the biological activities of the drug have been the most significant factor to be considered when choosing carriers for drug delivery. Drugs deteriorate in certain drug delivery systems due to adverse interactions with carrier molecules. To overcome such incidences, the carrier must be resistant to deteriorative reactions with the therapeutic agent and be able to deliver it to the particular site of the body without chemical changes. The degradation reactions caused by destructive interactions of drug and carrier molecules can be assessed using the UV–Vis spectra of pure drug and the drug released from the delivery carrier (Bashir et al. 2016). Curcumin contains three reactive functional groups linked with its various biological functions, as determined by its FTIR spectrum: one diketone moiety and two phenolic groups. Important chemical reactions related to its biological activity include the existence of C=O groups as hydrogen acceptors and C-4 as a hydrogen donor. These functional groups will also contribute to the antiviral properties of curcumin (Ahmed et al. 2017). In the UV–Vis spectrum, curcumin showed a strong absorption peak at 422 nm due to the low-energy π–π * chromophore excitation formed by the enolization of the diketone and its conjugation with vinylguaiacol’s p-electron clouds (Zsila et al. 2004). In this study, the drug (curcumn) is in contact with PVA, nanocellulose and acidic medium. Figure 10 shows the UV–Vis spectra of the pure drug (curcumin) and release drug from CNC/PVA/curcumin nanoparticles into the acidic medium. It can be seen that the 422 nm peak in both spectra remained intact, with no movement in the spectrum's upward or downward direction. Hence, it can be concluded that the functional groups of curcumin, which corresponds to its therapeutic properties were preserved without any degradative reaction with CNC, PVA or released acidic medium.

Fig. 10.

UV–Vis spectra of pure curcumin and curcumin released from nanocellulose into acidic medium

Future studies will be focused on the determination of the antiviral activity of CNC/PVA/curcumin nanoparticles against SARS-CoV-2. In research and clinical contexts, combined reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR (qPCR) are frequently used for gene expression profiling and viral RNA quantification. In future studies, real-time quantitative PCR (qRT-PCR) will be used to determine the antiviral activity of CNC/PVA/curcumin against SARS-CoV-2. The decrease in viral titer of coronavirus-infected cells will be used to assess antiviral efficacy (Freeman et al. 1999; Keyaerts et al. 2009).

The main advantages of inhaled medications are the delivery of drug directly into the airways, greater local concentrations, and a lower chance of systemic adverse effects. However, incidences of side effects from some inhaled drugs depositing locally in the oropharynx and larynx have been reported. The frequency of complaints is determined by the type of drugs, dosage, administration frequency, inhaler method, and delivery mechanism. Dysphonia (a hoarse voice) is a common complaint among glucocorticoid inhaler users. But it was reported that hydrofluoroalkane inhalers have a lower risk for dysphonia than older chlorofluorocarbon inhalers. Also, the risk of dysphonia may be lower with budesonide dry powder inhaler compared with chlorofluorocarbon or fluticasone propionate dry powder inhalers (Saag et al. 2015). In addition, cough is an adverse effect associated with dry powder inhalers that may hinder the delivery of drugs into the lungs. Controlling the particle size of the formulation to < 5 μm is required to reduce cough and ensure that the particles land in the deep lung, where cough receptors are absent. However, such an approach would need to consider the site of therapeutic action (Chang et al. 2020). A carrier material is required in most powder-dispensing devices. This vehicle material is combined with the medication to help the powder flow through the device more easily. Lactose and glucose are two types of the carriers utilized in powder-dispensing devices. Even though these substances are substantially greater than the drug (98% or more), allergic reactions to lactose and glucose appear to be fewer (Laube and Dolovich 2014). The acute inhalation toxicity of nanocellulose has been investigated in previous studies. Endes et al. (2014) investigated nebulized concentrations of CNC from 0.14 to 1.57 µg/cm² and found no significant cytotoxicity in 3D human airway barrier model. In another study, Lopes et al. (2017) found that cellulose nanofiber exposure did not induce cytotoxicity in any of the cell lines (human dermal, lung, and immune cells) examined up to 500 µg/mL for 24 h of exposure.

In addition to determining the antiviral activity of CNC/PVA/curcumin nanoparticles, the toxicity of the CNC/PVA/curcumin complex on human airway cells from various parts of the respiratory tract will be investigated with different concentrations of CNC/PVA/curcumin in the future studies. This will be based on the cell culture studies of primary human airway epithelial cells, cell viability assay studies and cell morphological investigations (Ferreira Lopes et al. 2017; Loutfy et al. 2020).

Conclusion

In this study, CNC/PVA/curcumin nanoparticles were prepared with enhanced drug loading properties. The possibility of its use as an inhalable nanotherapeutic to treat the SARS-CoV-2 was discussed. The extracted nanocellulose showed more densely packed fibrous networks with a diameter ranged from 50 to 100 nm. The extracted curcumin was characterized by FTIR spectroscopy and showed characteristic peaks similar to those obtained by previous studies and commercial curcumin. The solubility of curcumin increased from 2.85 ± 0.06 to 313.61 ± 1.05 mg/L with increasing the PVA concentration from 0.05 to 0.8 (w/v%) in acidic medium. This was a considerable improvement compared to the use of carboxymethyl cellulose in our previous study. Also, PVA does not affect the viscosity of the medium and the dispersibility of nanocellulose. The drug loading capacity of CNCs increased up to 8.90 ± 0.2 mg/g with the addition of 0.8% PVA to the drug loading medium, which was a 22-fold increase compared to the aqueous curcumin medium. All the formulations showed initial burst release, and the highest drug release showed by CNC/PVA0.8/curcumin formulation, which was 17.11 ± 0.22 mg/L at around 390 min. Drug activity studies showed that the functional groups of curcumin, which corresponds to its therapeutic properties, preserved without any degradative reaction with CNC, PVA or released acidic medium. According to the results, we believe that the CNCs’ morphology, surface characteristics, well-reported curcumin antiviral activity, and enhanced drug loading capacity will provide these formulations a suitable candidate for designing antiviral nanotherapeutics against SARS-CoV-2. This study highlights in vitro studies and future studies of these formulations will focus on determining the antiviral activity of CNC/PVA/curcumin nanoparticles against SARS-CoV-2.

Declarations

Conflict of interest

The authors declared no conflict of interest.

Human and animal rights

This manuscript does not contain any studies with human participants or animals performed by any of the authors.